Methylene Blue (General Injectables & Vaccines, Inc)


Welcome to the PulseAid listing for the Methylene Blue drug offered from General Injectables & Vaccines, Inc. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: General Injectables & Vaccines, Inc
NON-PROPRIETARY NAME: Methylene Blue
SUBSTANCE NAME: METHYLENE BLUE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2010-04-01
END MARKETING DATE: 0000-00-00


Methylene Blue HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethylene Blue from General Injectables & Vaccines, Inc
LABELER NAME: General Injectables & Vaccines, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2010-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52584-504_5d5c3c13-aeda-4706-ae94-3dba0faccbd1
PRODUCT NDC: 52584-504
APPLICATION NUMBER:

Other METHYLENE BLUE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Methylene Blue
American RegentPROVAYBLUE
General Injectables & Vaccines, IncMethylene Blue